Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123873935 | 12387393 | 5 | F | 20160318 | 20160902 | 20160519 | 20160912 | EXP | PHJP2016JP012114 | NOVARTIS | 75.79 | YR | F | Y | 56.00000 | KG | 20160912 | COUNTRY NOT SPECIFIED | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123873935 | 12387393 | 1 | PS | COSENTYX | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QW | 1500 | MG | Y | 125504 | 300 | MG | INJECTION | /wk | |||
| 123873935 | 12387393 | 2 | SS | TRAMCET | ACETAMINOPHENTRAMADOL | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 123873935 | 12387393 | 3 | SS | URSO | URSODIOL | 1 | Oral | 3 DF, BID | 0 | 3 | DF | TABLET | BID | ||||||
| 123873935 | 12387393 | 4 | SS | CELECOX | CELECOXIB | 1 | Oral | 100 MG, BID | 0 | 100 | MG | TABLET | BID | ||||||
| 123873935 | 12387393 | 5 | SS | DEPAS | ETIZOLAM | 1 | Oral | 1 MG, QD (1-3 MG QD) | 0 | 1 | MG | TABLET | QD | ||||||
| 123873935 | 12387393 | 6 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, QD | 0 | 20 | MG | CAPSULE | QD | ||||||
| 123873935 | 12387393 | 7 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | 100 MG, BID | 0 | 100 | MG | TABLET | BID | ||||||
| 123873935 | 12387393 | 8 | C | EDIROL | ELDECALCITOL | 1 | Unknown | 0.75 UG, QD | 0 | .75 | UG | CAPSULE | QD | ||||||
| 123873935 | 12387393 | 9 | C | ZACRAS | AMLODIPINE BESYLATEAZILSARTAN | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123873935 | 12387393 | 1 | Psoriatic arthropathy |
| 123873935 | 12387393 | 2 | Rheumatoid arthritis |
| 123873935 | 12387393 | 3 | Dyspepsia |
| 123873935 | 12387393 | 4 | Analgesic therapy |
| 123873935 | 12387393 | 5 | Mental disorder |
| 123873935 | 12387393 | 6 | Gastric ulcer |
| 123873935 | 12387393 | 7 | Gastric ulcer |
| 123873935 | 12387393 | 8 | Osteoporosis |
| 123873935 | 12387393 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123873935 | 12387393 | OT |
| 123873935 | 12387393 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123873935 | 12387393 | Condition aggravated | |
| 123873935 | 12387393 | Interstitial lung disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123873935 | 12387393 | 1 | 20160219 | 20160318 | 0 | |
| 123873935 | 12387393 | 2 | 201212 | 0 | ||
| 123873935 | 12387393 | 3 | 201212 | 0 | ||
| 123873935 | 12387393 | 4 | 201212 | 0 | ||
| 123873935 | 12387393 | 5 | 201212 | 0 |